新人到来，多帮忙啊。 ATHX可能有戏。

牛马熊

Athersys, Inc. (Nasdaq:ATHX) announced today that it has been granted U.S. patent 7,659,118 that covers non-embryonic multipotent stem cells, their isolation and expansion, and related pharmaceutical compositions. Athersys also announced that it has been granted -- and the opposition period has cleared -- EP patent EP1218489B1 that covers non-embryonic pluripotent stem cells, their isolation, expansion, and usage.
Athersys Receives U.S. Patent Covering Adult Stem Cell Composition & Production

锦衣卫

spo

这个专利的威力有没有FDA批一个药差不多大？

jack3400

be patient! it will slowly drop down to $2.5 range.